Radiol Oncol 2004; 38(3): 227-34. Comparison of Wistar vs. Fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumors Željka Večerić, Anton Cerar Medical Experimental Center, Institute of Pathology, University of Ljubljana, Slovenia Background. Many investigators have observed differences in the susceptibility to induce intestinal tumors by 1,2-dimethylhydrazine (DMH) between various strains of rodents. The results are difficult to compare because of the different regimes used for induction. The purpose of our study was to evaluate the influence of strain on DMH-induced intestinal tumors between Wistar and Fischer rats. Materials and methods. We used 29 Fischer and 30 Wistar male rats that were injected subcutaneously DMH, weekly, at a dosage of 25 mg/kg-body weight for 20 weeks. After 25 weeks from the beginning of the experiment, the animals were sacrificed and autopsied. The complete length of colorectum and all macro-scopic changes were examined histologically. Results. The induction of intestinal tumors was 97% in Fischer rats and 100% in Wistar rats. In Wistar rats 184 tumors were found: 133 adenomas, 50 tubular adenocarcinomas and 1 signet-cell carcinoma. 77% of carcinomas were found in colorectum and 23% in the small intestine. In Fischer rats, 126 tumors were found: 94 adenomas, 26 tubular adenocarcinomas, 5 signet-cell carcinomas and 1 mucinous carcinoma; 42% of carcinomas were found in the colorectum and 58% in the small intestine. The strain difference in the in-cidence of all induced tumors was statistically significant (P=0.001). The differences in the occurrence of the malignant and benign tumors was also significant (P<0.001; P=0.011). Extra intestinal tumors were not found. Conclusions. Wistar rats showed greater percentage of colorectal tumors, and also the distribution of tumors in colorectum resembled more the distribution found in human pathology. That is why we recommend Wistar rat rather than Fischer rat for the research work on the colorectal tumors. Key words: intestinal neoplasms – chemically induced; 1,2 dimethylhydrazine; rats, inbred F344; rats Wistar Received 17 May 2004 Accepted 10 June 2004 Correspondence to: Željka Večerić, Robičeva 2, 1000 Ljubljana, Slovenia. Tel: +386 31 580 325; E-mail: zelj-ka.veceric@email.si Introduction Colorectal carcinoma (CRC) is one of the leading causes of cancer mortality in the USA.1 With respect to its incidence as well as mortality rate, CRC takes the second place in Slovenia.2 This was the reason for much in- 228 Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats terest in the research of this disease and for highlighting the need for animal models that would be comparable to human disease and would help in the study of etiology, patho-genesis and therapy of the human disease. Some studies compared the incidence of experimentally induced intestinal tumors be-tween different species of experimental ro-dents and different strains among the species and demonstrated that susceptibility to car-cinogen and the incidence and distribution of tumors which developed is species-, strain-, and sex-dependant.3-8 Wistar and Fischer rats are among the most commonly used strains of rats in the research of intestinal cancer.9 The published information on the strain-re-lated differences between them is scarce. Besides the results are difficult to compare because different carcinogenic substances, doses, application regimes and application sites are used. So, we decided that this issue is worth of further studies. Materials and methods Animals We used 29 Fischer (344) and 30 Wistar (Hannover) male rats from The Medical Experimental Center, Ljubljana, Slovenia. They were 8-10 weeks old. The experiment was carried out in accordance with the permission of The Veterinary Administration Board of The Republic Slovenia. At the onset of the experiment the weight of Wistar rats ranged between 170–340 g and that of Fischer rats between 180–290 g. The experiment was carried out at a room temperature of 20–23°C, humidity 40–70%, and at a natural light cycle. The animals were pro-vided pelleted M-K-02 food (Biotechnical Faculty, Ljubljana) and tap water ad libitum. Carcinogenic agent CRC was induced by means of 1,2-dimethyl-hydrazine (DMH) (Fluka Chemie, Switzer-Radiol Oncol 2004; 38(3): 227-34. land) prepared according to the standard method10: DMH-HCl was dissolved in 0.001 M EDTA and pH value adjusted to 6.5 using 0.1 M NaOH solution. Fresh solutions were prepared once weekly. Study design The dose of DMH was adjusted accordingly, so that it always amounted to 25 mg/kg of body weight. The solution was injected sub-cutaneously into the skin fold on the hip once weekly throughout a period of 20 weeks. The animals were left to live four weeks after completed DMH injection and thereupon sac-rificed by CO2 inhalation. The body weight was controlled every two weeks. Morphology During autopsy, all internal organs except the central nervous system were examined. Attention was paid also to the possible pres-ence of tumors in the outer auditory canal. The stomach was opened via the major curve while the intestine was approached longitudi-nally on the antimesenterial side. After open-ing, the organs were rinsed with water. The distal part of the ileum, large intestine, anus and neoplasms in the small intestine were spread over a polystyrene board, with intesti-nal mucosa facing upwards, and fixed in 10% buffered formaldehyde. The total length of colorectum and all macroscopically visible lesions were sampled for the histological exam-ination. The tissue samples were paraffin em-bedded and cut into 4.5 µm thick histological sections. The sections were stained by Kreyberg trichrome method. In the cases when histological picture or tumor stage could not be determined from a single sec-tion, stepwise deeper sections were made. All intestinal lesions were assessed according to histological criteria used in human pathology and the stages of carcinomas defined follow-ing Duke’s staging system: - Stage A: tumor is limited to the intestinal wall; Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats 229 Table 1. Distribution and number of intestinal tumors TUMOR LOCATION No (%) Small intestine Colon ascendens Colon transversum Colon descendens with rectosigmoid FISCHER WISTAR 21(17) 7(4) 16(13) 14(8) 47(37) 57(31) 42(33) 106(57) - Stage B: tumor grows through the lamina muscularis propria; - Stage C: tumor grows through the lamina muscularis propria and disseminates into the lymph nodes; - Stage D: distant metastases.11 Histological criteria for the diagnosis of adenoma were: (1) cytological – increased mi-totic activity, polymorphism and hyperchro-matism of the nuclei, basophilia of the cyto-plasm, decreased mucine excretion and (2) histological – stratification of the nuclei, ir-regular proliferation of the glandular formations. Smaller tumor lesions composed of 2-5 crypts (microadenomas), seen only histologi-cally, were also statistically processed. The criterion for diagnosis of carcinoma was the evidence of tumor growth through the muscularis mucosa. In the case the lesion was suspected of being malignant while there was no clear evidence of tumor growth through the muscularis mucosa, the follow-ing additional histological criteria for carcino-ma were used: a sharp transition of normal epithelium to severely dysplastic epithelium, the presence of significant necrosis on the surface of tumor and desmoplastic stromal reaction. Statistical methods The significance of strain-related difference in the numeric results was tested for the dif-ference between proportions by computer software StatGrafics®Plus. Results Number and distribution of intestinal tumors All animals survived throughout the duration of the experiment. In the intestine of Fischer and Wistar rats 126 and 184 tumors were found, respectively. The tumors were in-duced in 97% of Fischer rats and 100% of Wistar rats, while the tumors of the colorec-tum were induced in 48% of Fischer and in 83% of Wistar rats (Table 1). The strain dif-ference in the incidence of all induced tumors was statistically significant (P=0.001). Extra-intestinal neoplasms were not found. The microadenomas that were evaluated by the systematic histological examination of the whole length of the colorectum represent-ed 70% of tumors in Fischer and 60% of tumors in Wistar rats. In Fischer rats, 25% of the induced tumors were carcinomas that were mostly found in the small intestine (58%), followed by the as- Table 2. Histological types and stages of intestinal tumors according to Duke’s system HISTOLOGIC TYPES OF TUMORS Adenomas Tubular Signet-ring cell adenocarcinomas carcinomas Mucinous carcinomas ABCD ABCD A B CD FISCHER 94 19700 3200 0100 WISTAR 133 41801 1000 0000 Radiol Oncol 2004; 38(3): 227-34. 230 Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats Figure 1. Segment of the large bowel with five tumors giving the appearance of chain-like arrangement. cending colon (23%), descending colon with rectosigmoid (16%) and the transverse colon (3%). In Wistar rats, 30% of tumors were carci-nomas and were located in the transverse colon (39%), descending colon with rectosig-moid (37%), small intestine (14%) and ascend-ing colon (10%). The most of the small intesti-nal tumors were found in duodenum. Macroscopic appearances and histological exami-nation Macroscopically, tumors grew as plaques or as polypoid lesions on stalk or formed ''nap-kin ring'' masses. In 73% of Wistar rats, multiple colorectal tumors were found. The ma-jority of those tumors was strung closely to- Figure 3. Adenocarcinoma stage Dukes B. On the left site there is a large bowel wall with a lymphatic folli-cle next to tumor tissue that invades the whole bowel wall (40X magnification). Radiol Oncol 2004; 38(3): 227-34. 100% 80% 60% 40% 20% 0% Fischer Wistar 14% 7% 0%0% 0%0% A BC D Stages of colon carcinomas Figure 2. Comparison of colonic tumor stages in Wistar and Fisher rats. gether and gave the appearance of ''chain of tumors'' (Figure 1). The latter consisted of 3-8 tumors and were mostly located in the transverse and the descending colon with rectosig-moid. Five Wistar rats presented such chains, while none was found in Fischer rats. In the review of histological samples in Wistar rats 133 adenomas, 50 tubular adeno-carcinomas and 1 signet-ring cell carcinoma were found. In Fischer rats, the histological examination revealed 94 adenomas, 26 tubu-lar adenocarcinomas, 5 signet ring-cell carci-nomas and 1 mucinous carcinoma (Table 2). Most tubular adenocarcinomas were well-differentiated lesions. They grew mostly as polypoid or papillary growths into the lumen. On the contrary, signet-ring cell carcinomas were mostly small, plaque-like lesions with prominent invasion into the deeper levels of the bowel wall. In both strains, signet-ring cell carcinomas were found in the ascending colon with only one tumor being located in the small intestine. The difference in the occurrence of the ma-lignant and benign tumors between the strains was statistically significant (P<0.001; P=0.011). We also found a relation between intesti-nal lymphoid tissue and tumor location. More than a half of the carcinomas were found in the vicinity of the lymphoid follicles. In one Wistar rat, intussusception connected with tumor in the transverse colon was observed. Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats 231 Figure 4. Distribution of intestinal carcinomas in Fischer vs. Wistar rats (each spot represents one tumor). Staging of the intestinal carcinomas In Wistar rats, the majority of tumors (82%) were found in stage A, 16% were in stage B (Figure 3), and 2% in stage D according to Duke’s system (Table 2). Only 3% of tubular adenocarcinomas stage A were found in the small intestine, while 46% were found in the transverse colon, 41% in the descending colon with rectosigmoid and 10% in the as-cending colon. The adenocarcinomas stage B were found mostly (63%) in the small intes-tine, 25% in the descending colon with rec-tosigmoid and 12% in the transverse colon. Only one signet-ring cell carcinoma was found in the ascending colon. In one rat, we found a carcinosis of the liver and peri-toneum (Dukes D). The comparison of stages of only colorectal carcinomas between differ-ent strains of rats is shown in Figure 2. In Fischer rats, 68% of carcinomas were stage A, 32% stage B, while other stages were not found; 56% of adenocarcinomas stage A and 75% stage B carcinomas were found in the small intestine, while others were located in the descending colon with rectosigmoid (22%), transverse (10%) and the ascending colon (10%). The adenocarcinomas in stage B were similarly distributed: small intestine (75%), descending colon with rectosigmoid (12.5%), and ascending colon (12.5%). The signet-ring cell carcinomas presented 12.5% of all carcinomas in Fischer rats and all were found in the ascending colon. The distribution of induced intestinal carcinomas in Fischer and Wistar rats is schematically pre-sented in Figure 4. Discussion DMH injected subcutaneously is one of the most effective CRC inducers in small rodents. This substance has been studied in large-scale experiments12-19, but the incidence of experimentally induced tumors in different strains of animals was not clearly defined. No data can be found in literature comparing DMH-induced tumors in Wistar and Fischer strains, although those are most often used for experimental purposes.9 Radiol Oncol 2004; 38(3): 227-34. 232 Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats The intestinal tumors were induced in 97% of Fischer and 100% of Wistar rats. Though there was no significant difference in the share of animals affected with tumors be-tween the two strains , the incidence of in-testinal tumors was significantly higher in Wistar rats. Nevertheless, we have to emphasize that the microadenomas containing 2-5 aberrant crypts were also included in analysis. Microadenomas presented almost 70% of all tumors found and their frequency supports the likeli-hood that CRC develop from adenomas.5,6,21-23 Because of the inclusion of microadenomas, the total number of induced tumors in our study somewhat exceeded the number of tumors induced by the same dose and number of applications by other authors.6,7,23-25 Fischer rats developed markedly less carci-nomas than Wistar rats; 58% of them were found in the small intestine, others were equally distributed in the ascending and de-scending colon. There were, however, less tumors found in the transverse colon than re-ported by other authors.9,23-25 The tumors of the small intestine, which were mainly well differentiated adenocarcinomas, developed most often in the proximal part of the small intestine. Macroscopically, both strains de-veloped polypoid, cauliform lesions and also ring-like lesions with elevated edges that were comparable with human disease. Sessile tumors exhibiting endophytic growth pattern were rare. In our study, the histological types of in-testinal tumors in rats are consistent with those of other authors who report the greatest number of well differentiated adenocarcino-mas and some signet-cell carcinomas, while poorly differentiated adenocarcinomas were rarely found.20-23,26 Our results of tumor stage analysis were comparable with those obtained by other au-thors, according to which a majority of col-orectal tumors (75%) were in stage A.20-23,26 Our comparison of carcinoma stage by strain has shown noteworthy differences. Fischer rats developed twice as much stage B tumors than Wistar rats. The tumors found in Fischer rats were showing more invasiveness and were usually growing deeper in the bowel wall. Likewise some other authors, we also found a case of stage D tumor, with peritoneal carcinosis and distant metastases.5, 20-22 The analysis of the small intestinal tumors revealed differences between the two strains in regard to stages: well or moderately differ-entiated adenocarcinomas stage B predomi-nated in Wistar strain and well differentiated adenocarcinomas stage A in Fischer rats. Most of the macroscopically visible small in-testinal tumors were located in the proximal part (duodenum, proximal jejunum), which is consistent with the carcinoma of the small in-testine in humans. An association of DMH-induced rat col-orectal tumors with colorectal lymphoid folli-cles was observed previously, but not quanti-fied. Our experiment revealed that more than 50% of carcinomas developed in the immedi-ate proximity of the intestinal lymphoid tis-sue. This is supposed to be an immunologic answer to antigenic components present in the tumor and simultaneously because of the more rapid replication of the epithelial cells in the vicinity of lymphatic tissue.27-29 Tumors found in both Wistar and Fischer strain histologically resembled those found in human pathology. Wistar rats have developed a greater incidence of colorectal tumors and distribution of tumors resembled more the distribution as it is seen in human pathology than those in Fischer rats. Therefore we recom-mend Wistar rats rather than Fischer rats for the research work on the colorectal tumors. Acknowledgements The authors wish to thank Mrs. Tadeja Klemenc and Mrs. Majda Prebil for the histo-logical samples preparation, Mrs. Ana Zebič, DVM for her valuable assistance with the ex- Radiol Oncol 2004; 38(3): 227-34. Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats 233 periment and Mrs. Martina Perše, DVM for her help with references, comments and sug-gestions. References 1. Boring CC, Sqires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994; 44: 9. 2. Register raka za Slovenijo. Incidenca raka v Sloveniji. Ljubljana: Onkološki inštitut v Ljubljani, 1994: 13. 3. Ishiguro Y, Ochinai M, Sugimura T, Nagao M, Nakagama H. Strain differences of rats in the sus-ceptibility to aberrant crypt foci formation by 2-amino-1-metyl-6-phenylimidazo-[4,5-b]pyridine: no implication of Apc and Pla2g2a genetic poly-morphisms in differential susceptibility. Carcino-genesis 1999; 20(6): 1063-8. 4. Evans JT, Hauschka TS, Mittelman A. Differential susceptibility of four mouse stains to induction of multiple large-bowel neoplasms by 1,2-dymethyl-hydrazine. J Natl Cancer I 1974; 52: 999-1000. 5. Melhem MF, Kunz HW, Gill TD. Genetic control of susceptibility to diethylnitrosamine and di-methylbenzanthracene carcinogenesis in rats. Am J Pathol 1991; 139: 45-51. 6. Teague CA, Gavin JB, Heridson PB. The response of three inbred strains of rat to the cancerogen 1,2-dimethylhydrazine. Pathology 1981; 13: 473-85. 7. Evans JT, Shows TB, Sproul EE, Paolini NS, Mittelman A, Hauschka TS. Genetics of colon car-cinogenesis in mice treated with 1,2-dimethylhy-drazine. Cancer Res 1977; 37: 134-40. 8. Breskvar L, Cerar A. A role of gender in the oc-curence of dimethylhydrazine induced colorectal tumors in Wistar rats. Radiol Oncol 1997; 31: 374-9. 9. Martin MS. Experimental intestinal carcinogene-sis. Cancer 1992; 5: 1-10. 10. Shamsuddin AKM. Carcinoma of the large intes-tine: animal models and human disease. Hum Pathol 1986; 17: 451-3. 11. Dukes C. The classification of cancer of the rec-tum. J Pathol Bacteriol 1932; 35: 313-32. 12. Toth B. Synthetic and naturally occuring hy-drazines as possible cancer causative agents. Cancer Res 1975; 35: 3693-7. 13. Fiala ES. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-di-methylhydrazine and azoxymethane. Cancer 1977; 40: 2436-45. 14. Fiala ES, Bobotas G, Kulakis C, Wattenberg LW, Weisburger H. Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen 1,2-dimethylhydrazine. Biochem Phar-macol 1977; 26: 1763-8. 15. Fiala ES, Sthathopoulos C. Metabolism of methy-lazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram. J Cancer Res Clin Oncol 1984; 108: 129-34. 16. Swenberg JA, Cooper HK, Bucheler J, Kleihues P. 1,2-dimethylhydrazine-induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram. Cancer Res 1979; 39: 465-7. 17. Zedeck MS, Stemberg SS, Pynter RW, McGowan J. Biochemical and pathological effects of methyla-zoxymethanolacetate, a potent carcinogen. Cancer Res 1970; 30: 801-12. 18. Fiala ES, Kulakis C, Christiansen G, Weisburger JH. Inhibition of the metabolism of the colon car-cinogen, azoxymethane by pyrazole. Cancer Res 1978; 38: 4515-21. 19. Fiala ES, Caswell N, Sohn OS, Felder MR, McCoy D, Weisburger JH. Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse Peromyscus maniculatus. Cancer Res 1984; 44: 2885-91. 20. Day DW. The adenoma-carcinoma sequence. Scand J Gastroenterol 1984; 19(Suppl 104): 99-107. 21. Hill MJ, Morson BC, Bussey HJR. Aetiology of ade-noma-carcinoma sequence in large bowel. Lancet 1978; i: 245-7. 22. Sunter JP. Cell proliferation in gastrointestinal car-cinogenesis. Scand J Gastroenterol 1984; 19(Suppl 104): 45-9. 23. Newberne PM, Rogers AE. Adenocarcinoma of the colon. Am J Pathol 1988; 72: 541-4. 24. Hagihara PF, Yoneda K, Sachattelo CR, Hedgecock H, Flesher JV, Ram MD, Griffen WO, Goldenberg DM. Colonic tumorigenesis in rats with 1,2-DMH: Dis Colon Rectum 1980; 23: 137-40. 25. Maskens AP. Histogenesis and growth pattern of 1,2-dimethylhydrazine-induced rat colon adeno-carcinoma. Cancer Res 1978; 36: 1585-92. Radiol Oncol 2004; 38(3): 227-34. 234 Večerić Ž and Cerar A / Chemically induced intestinal tumors in rats 26. Lipkin M, Deschner E. Early proliferative changes in intestinal cells. Cancer Res 1976; 36: 2665-8. 27. Rubio CA, Nylander G, Sveander M, Duvander A, Alun ML. Minimal invasive carcinoma of the colon in rats. Am J Pathol 1986; 123: 161-5. 28. Park HS, Goodland RA, Wright NA. The inci-dence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res 1997; 57(20): 4507-10. 29. Hardman WE, Cameron IL. Colonic crypts located over lymphoid nodules of 1,2-dimethylhydrazine-treated rats are hyperplastic and at high risk of forming adenocarcinomas. Carcinogenesis 1994; 15(10): 2353-61. Radiol Oncol 2004; 38(3): 227-34.